SCHEMBL23959205

SCHEMBL23959205

c1ccc(-c2nc3ncc(N4c5ccccc5N(c5ccccc5)c5ccccc54)cn3c2-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 8/20 0.47
▸ AKT2 P31751 8/20 0.47
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ USP2 O75604 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ ROCK2 O75116 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ BCHE P06276 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ GAA P10253 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MAPK13 O15264 1/20 0.33
▸ MAPK12 P53778 1/20 0.33
▸ MAPK11 Q15759 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959251 0.88 AKT1 (0.58) AKT1AKT2MEN1KMT2ASMN1; SMN2
SCHEMBL23959061 0.87 AKT1 (0.47) AKT1AKT2MEN1KMT2ASMN1; SMN2
SCHEMBL23959290 0.87 AKT1 (0.44) AKT1AKT2MEN1KMT2ASMN1; SMN2
SCHEMBL23959237 0.85 AKT1 (0.46) AKT1AKT2MEN1KMT2ASMN1; SMN2
SCHEMBL23959247 0.84 AKT1 (0.44) AKT1AKT2MEN1KMT2ASMN1; SMN2
SCHEMBL23959238 0.83 AKT1 (0.43) AKT1AKT2MEN1KMT2ASMN1; SMN2
SCHEMBL23959310 0.78 AKT1 (0.56) AKT1AKT2MEN1KMT2ASMN1; SMN2
SCHEMBL23959126 0.78 AKT1 (0.47) AKT1AKT2BCHEACHE
SCHEMBL23959103 0.77 AKT1 (0.46) AKT1AKT2MEN1KMT2ASMN1; SMN2
SCHEMBL23959305 0.76 AKT1 (0.44) AKT1AKT2MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885MEN1 301/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885MEN1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback